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ABSTRACT
Endogenous dermal stem cells (DSCs) reside in the adult hair folliclemesenchyme and can be isolated
and grown in vitro as self-renewing colonies called skin-derived precursors (SKPs). Following trans-
plantation into skin, SKPs can generate new dermis and reconstitute the dermal papilla and connec-
tive tissue sheath, suggesting they could have important therapeutic value for the treatment of skin
disease (alopecia) or injury. Controlled cell culture processes must be developed to efficiently and
safely generate sufficient stem cell numbers for clinical use. Compared with static culture, stirred-
suspensionbioreactors generated fivefold greater expansionof viable SKPs. SKPs fromeach condition
were able to repopulate the dermal stem cell niche within established hair follicles. Both conditions
were also capable of inducing de novo hair follicle formation and exhibited bipotency, reconstituting
the dermal papilla and connective tissue sheath, although the efficiency was significantly reduced in
bioreactor-expanded SKPs comparedwith static conditions.We conclude that automated bioreactor
processing could be used to efficiently generate large numbers of autologous DSCs whilemaintaining
their inherent regenerative function. STEM CELLS TRANSLATIONAL MEDICINE 2016;5:1–10
SIGNIFICANCE
Recentwork has demonstrated the existence of dermal stem cells (DSCs) that residewithin adult hair
follicles and might serve as a renewable source of inductive dermal cells to regenerate dermis or re-
juvenate dermal papilla to restore follicle growth. In order to realize this clinical potential, it is essen-
tial that in vitro bioprocesses are developed to rapidly and safely expand DSCs. The present study
showed that computer-controlled stirred suspension bioreactors can be used to efficiently and safely
generate large numbers of DSCs while maintaining their phenotype and at least some of their inher-
ent inductive function. This builds on a foundation of research supporting automated bioprocessing
as aneffective approach for culturing stemcells. Thebioprocess describedhas important implications
for ex vivo expansion of inductive dermal stem/progenitor cells that could be used for composite skin
engineering strategies, drug screens related to hair growth, and the regeneration of dermis within
severe skin wounds.
INTRODUCTION
The adult hair follicle (HF) is composed of mesen-
chymal cells that provide instructive signals to
regulate epithelial stem cell function during ho-
meostasis and tissue regeneration. Loss or dys-
function of the inductive mesenchyme residing
within the dermal papilla prevents the onset of
anagen hair growth and leads to hair loss [1].
Recent work has demonstrated the existence
of a self-renewing dermal stem cell (DSC) within
the adult mammalian skin [2, 3]. DSCs reside spe-
cifically in the HFmesenchyme and function to re-
plenish the dermal papilla and connective tissue
sheath (CTS) with each new regenerative hair cy-
cle. DSCs can be isolated in vitro (referred to as
skin-derived precursors or “SKPs”), where they ex-
hibit long-term self-renewal and can bepersuaded
to generate both mesodermal and neural deriva-
tives [2, 4–8]. When SKPs are transplanted to
full-thickness skin wounds, they give rise to a vari-
ety of fibroblast phenotypes and fill the lesionwith
new dermal tissue [2]. Transplanted SKPs are also
able to integrate into the mesenchyme of existing
HFs and initiate formation of new HFs when
cotransplanted with neonatal epithelial cells [2].
Thus, DSCs (or SKPs) represent a potentially
valuable source of multipotent, self-renewing
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dermal progenitors that could be used to repopulate the HFmes-
enchyme or the dermis after skin injury or disease. Like many
stem cell cultures, SKPs are typically grown in static tissue culture
flasks as nonadherent, self-renewing spherical colonies. Although
sufficient to generate cells for experimental purposes, this ap-
proach is impractical for generating the large quantities of SKPs
that would be required in an autologous clinical cell therapy to
repopulate the HF mesenchyme or dermis to enhance wound
healing. Not only are static tissue culturemethods time and labor
intensive, but also a requirement exists for manual handling and
inherent cellular variation between flasks [9]. Previous studies,
using cell types that included murine embryonic stem cells [10,
11], human embryonic stem cells [12], multipotent adult progen-
itor cells frombonemarrow [13], neural precursor cells [14],mes-
enchymal stem cells [15], and induced pluripotent stem cells [16]
have all shown that stirred suspension bioreactors are an effec-
tive alternative for culturing stem cells. Stirred suspension biore-
actors offer several advantages over static cultures, including
reduced labor and operating costs, higher yield, greater cellular
homogeneity, reduced space requirements, and increased cell
density per volume [17]. They also allow for precise monitoring
and control of key process variables. Controlling the physiochem-
ical environment (pH and dissolved gas), nutrient andmetabolite
concentrations, and growth factors to most closely recapitulate
their in vivo niche [18] will be imperative for translation to clinical
applications and establishing Current Good Manufacturing
Process-compatible bioprocesses [19]. The shear stresses pro-
duced in stirred suspension bioreactors can stimulate intracellu-
lar pathways governing expansion. In vivo, the cells are exposed
to a combination of biochemical and physical cues that regulate
their function. Mechanical stimulation, in particular, shear stress
ex vivo, is acknowledged as having the ability to enhance both
proliferation and differentiation of stem cells, making the effect
of physical forces important for tissue engineering [20].
In the present study, we first queried whether computer-
controlled, stirred suspension bioreactors could be used to en-
hance expansion of primary adult SKPs in vitro. Next, we tested
whether their endogenous bipotency and HF inductive func-
tion could be sustained over multiple passages in bioreactors
in vitro.
MATERIALS AND METHODS
Adult Rat SKP Isolation
Rat SKPs (rSKPs)were isolated fromtheback skinofP30malegreen
fluorescent protein (GFP)-expressing SpragueDawley rats (Sadaaki
Takagi Japan SLC, Hamamatsu, Japan, http://www.jslc.co.jp) after
an overdose of sodium pentobarbital (27.3 mg/kg, intraperitoneal
injection), according to previously described protocols [21]. Pri-
mary dermal cells were grown in basic fibroblast growth factor
(40 ng/ml; BD Biosciences, San Jose, CA, http://www.bdbiosciences.
com), platelet-derived growth factor (PDGF)-BB (25 ng/ml; R&D
Systems, Minneapolis, MN, http://www.rndsystems.com), B27
supplement (2%; Thermo Fisher Scientific Life Sciences, Waltham,
MA, http://www.thermofisher.com) and penicillin/streptomycin
(1%; Thermo Fisher Scientific Life Sciences) in Dulbecco’s modified
Eagle’s medium (DMEM) low glucose/F12 (3:1; Thermo Fisher Sci-
entific Life Sciences). SKPswere plated at 30,0000 cells permilliliter
in suspension culture flasks (Falcon). Following primary colony for-
mation, SKPs were dissociated to single cells using collagenase
digestion (2 mg/ml; Worthington Biochemical Corp., Lakewood,
NJ, http://www.worthington-biochem.com) and replated at
30,000 cells permilliliter. SKPs were passaged three or four times
in static culture before being introduced to the bioreactor expan-
sion to obtain sufficient numbers of cells to seed into the 500-ml
bioreactors at 30,000 cells per milliliter.
Serial Passaging
The overall experimental design is shown in Figure 1. rSKPs from
each animal were cultured for three consecutive passages in
500-ml computer controlled DASGIP Parallel Bioreactor Systems
(Eppendorf, Hamburg, Germany, http://www.eppendorf.com)
and, in parallel, in T75 suspension culture flasks (Cellstar; Greiner
Bio One, Kremsmu¨nster, Austria, http://www.gbo.com). For all
passages, the variable bioreactor set points were regulated at
60 rpm, 37°C, pH 7.4, and a 21% dissolved oxygen concentration.
rSKPs in static culture flaskswere grown in a humidified incubator
at 37°C and 5% CO2 in air. rSKPs were inoculated at 30,000 cells
per milliliter and cultured for 7 days. On day 7 of each passage,
rSKP aggregates were dissociated using collagenase digestion
and counted by standard trypan blue exclusion. The cells were
fed on days 3 and 6 of each passage with the growth factors
B27 and penicillin/streptomycin. DASGIP Parallel Bioreactor Sys-
tems (Eppendorf) were taken offline to allow each passaging and
feeding procedure to be conducted in a sterile biosafety cabinet.
Analysis of Cell Growth Kinetics
Cell counts were performed at day 7 to calculate the multiplica-
tion ratios and cumulative multiplication ratios at each passage.
Multiplication ratios were defined as the final viable cell density
divided by the inoculation density (30,000 cells per milliliter). Cu-
mulative multiplication ratios were defined as the product of the
individual passagemultiplication ratios for that culture condition.
Toanalyze theexponential doubling timesandapparentgrowth
rates in the DASGIP Parallel Bioreactor System (Eppendorf), cell
counts were performed each day. Two samples of 2.0 ml were col-
lected through a one-way valve sample port using a 3-ml manual
screwdispensing syringe. Each samplewas dissociated and counted
twice. The results were used to generate viable cell density growth
curves. The exponential phase doubling time and the apparent
growth rateover the courseof eachpassageweredeterminedusing
Equations 1 and 2:
X2 ¼ X1e2mDt ð1Þ
tD ¼ lnð2Þ=m ð2Þ
whereX is the viable cell density at agiven timepoint (cells per
milliliter),m is thegrowth rate (h21), t is the time inhours, and tD is
the population doubling time in hours.
The exponential doubling time (tD) was defined as the time
required for the cell population to double in size during exponen-
tial growth (X1, X2, and Dt = t2 2 t1 chosen during exponential
phase), following the lag phase. The apparent growth rate (mApp)
related the change in cell concentration from the inoculation
density (X1 = X0) to the final exponential growth concentration
(X2 = XF) over the entire passage (Dt = tF 2 t0).
Assessment of Aggregate Size
An aggregatewas defined as a groupof cells.40mmindiameter.
For both bioreactor and static culture conditions, the aggregate
diameter was measured for 60 aggregates (n = 20 per animal, 3
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animals for each condition) at the end of each serial passage. Ag-
gregate sizewas determined by takingmultiple 1.0-ml samples to
be imagedusing a ZeissAxiovert 25microscope (Carl ZeissMicros-
copy, Thornwood, NY, http://www.zeiss.com).
Homing Assay
GFP expressing rSKPs grown in either bioreactor or static cultures
were dissociated as described. One million cells were resus-
pended in 30 ml of DMEM and injected intradermally in the back
skin of 4-week-old male nonobese diabetic/severe combined im-
munodeficiency mice, as described previously [2]. One static
rSKPs and one bioreactor rSKPs graft were included on each
mouse. Theback skinwas depilated after 1month to reset anagen
growth and assess the fate of SKPs over successive cycles. Ten
days later, the mice were euthanized. The transplant site was
identified by GFP labeling and collected and fixed in 4% parafor-
maldehyde (PFA).
Ex Vivo HF Formation Assay
HF formation assays were performed as previously described [2,
22]. Four-week-old male nude mice (Nu/Nu) were anesthetized
and injected subcutaneously with rSKP/keratinocyte suspension
(15,000 epithelial aggregates combined with 106 SKPs in 80 ml
DMEM). One injection with static-grown rSKPs and one injection
with bioreactor-grown rSKPs were performed per mouse. The
grafts were left in place for 2 weeks, after which the mice were
euthanized by CO2 and the back skin was collected.
Tissue Preparation and Analysis
The mice were given an overdose of sodium pentobarbital, and
the back skin was removed and subsequently fixed overnight in
4% PFA at 4°C and then placed in increasing sucrose solutions
at 4°C each overnight (10%, 20%, and 30% sucrose) before being
snap frozen in blocks of OCT in liquid nitrogen-cooled isobutane
and stored at 280°C. The skin was sectioned at 30-mm thick-
nesses using a Leica CM1950 cryotome (Leica Biosystems, Buffalo
Grove, IL, http://www.leicabiosystems) for immunohistochemi-
cal analysis (n = 24 sections per animal; 3 animals for each condi-
tion). The grafts were fixed overnight in 4% PFA at 4°C then
changed to phosphate-buffered saline (PBS) overnight at 4°C.
The total number of GFP+ HFs was counted using a Zeiss Lumar
V12 Stereo microscope, and higher magnification imaging was
done with a Zeiss Observer microscope using Axiovision software
(Carl Zeiss Microscopy).
Immunofluorescence Staining
Bioreactor and static cell cultures were analyzed after three con-
secutive passages. The cells were immobilized on slides using a
Cytospin (Shandon; Thermo Fisher Scientific Life Sciences) at
8,000 rpm for 5 minutes. The cells were blocked overnight at
4°C in 10% donkey serum/0.5% Triton-X PBS. Primary antibodies
were diluted in 1% donkey serum in PBS and incubated overnight
at 4°C. Secondary antibodies were used at 1:500 in PBS and incu-
bated overnight at 4°C.
The skin sections were incubated in 10% donkey serum/0.5%
Triton-X 100 in PBS for 2 hours at room temperature. Primary an-
tibodies were diluted in 1% donkey serum PBS and incubated
overnight at 4°C. Secondary antibodies were used at 1:500 in
PBS and incubated for 2 hours at room temperature. Nuclei were
labeled using Hoechst at 1:1,000, and the slides were coverslip-
ped using Permafluor mounting medium (Thermo Fisher Scien-
tific Life Sciences).
Figure 1. Experimental timeline for cell inoculation, serial passaging in bioreactor and static conditions, and patch assay and homing assay
transplantations. Abbreviations: d, day; NOD/SCID, nonobese diabetic/severe combined immunodeficiency; SKP, skin-derived precursor.
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Flow Cytometry
Bioreactor and static cell cultures were analyzed after three con-
secutive passages. rSKP spheres were centrifuged at 600g for 5
minutes, and the supernatant was removed and discarded. Cells
were dissociated to single cells, fixed in 4% PFA at room temper-
ature for 30minutes beforebeing centrifugedagain, resuspended
in 2ml of PBS, and kept at 4°C. The cells were blocked for 30min-
utes at room temperature in 10% donkey serum/0.5% Triton X
PBS. Primary antibodies were diluted in 1% donkey serum in
PBS and incubated for 30minutes at room temperature. Second-
ary antibodies were used at 1:100 in PBS and for 30 minutes at
room temperature. SKPswere analyzedwith a FACSARIA III sorter
(BD Biosciences); 10,000 events were collected for each antibody
of interest, and gates were set according to unstained and sec-
ondary only controls (in the absence of isotype controls). Cytom-
etry data presentation was done with FLoJo (Tree Star, Ashland,
OR, http://www.flowjo.com).
Statistical Analysis
All statistical analyses were undertaken using GraphPad
Prism, version 6.0 (GraphPad, San Diego, CA, http://www.
graphpad.com). A two-tailed Student t test or two-way anal-
ysis of variance was used, followed by Sidak’s multiple com-
parison test. Cell counts and aggregate sizing were pooled
for each passage from 3 mice. Differences were considered
statistically significant at p , .05. All in vitro graphs are pre-
sented as mean 6 SEM.
RESULTS
Computer Controlled Bioreactors Enhance Expansion of
rSKPs Over Multiple Passages Relative to Static Culture
SKP cells from GFP-expressing rats (n = 3; rSKPs) were cultured
in parallel static and bioreactor conditions for three consecu-
tive passages (Fig. 1). After 7 days, aggregates were dissociated
into single cells and reinoculated in static or bioreactor condi-
tions (Fig. 2A).
Cell counts were performed daily for bioreactor culture and,
on day 7, for static culture. The expansion of rSKP cells decreased
significantly between serial passages 1 and 2 in bioreactor and
static culture and between serial passages 2 and 3 in bioreactor
culture (Fig. 2B). However, by the third consecutive passage,
the total expansion of rSKP cells in bioreactor culture was signif-
icantly greater than in static culture (Fig. 2C). The average cumu-
lative multiplication ratios at the end of the three serial passages
in bioreactor and static conditions were 43.66 20.1 and 7.916
0.99 respectively, indicating a fivefold increase in overall expan-
sion in the bioreactors.
Although the total expansion of rSKP cells was greater in bio-
reactor than in static culture, the average aggregate size of rSKP
cells grown inbioreactor culturewas significantly smaller than the
average aggregate size of rSKP cells grown in static culture (Fig.
2D). These results were consistent for each passage. This differ-
ence is also qualitatively displayed in Figure 2A, inwhich a distinct
difference in aggregate size canbeseenbetween theday7 images
of the bioreactor and static cultures. The exponential doubling
times in the bioreactors were calculated for each passage and
the results pooled. No significant difference was seen between
passages (Fig. 1E).
The DASGIP Parallel Bioreactor System (Eppendorf) allows for
continuous feedback control over the dissolved oxygen concentra-
tion and the pH of themedium. Over the three serial passages, the
bioreactor cultures were regulated at 21% dissolved oxygen con-
centration (Fig. 2F). The input oxygen percentage in the headspace
gas increased in a linear fashion between days 1 and 7 of each pas-
sage. The average inoculation pH of the rSKP culture proliferation
mediumwas 7.696 0.03 at the beginning of each passage. The pH
was regulated at7.4overeach serial passageby theadditionof car-
bon dioxide to the headspace gas (Fig. 2G). As a result of the high
initial pH, the DASGIP Parallel Bioreactor System (Eppendorf) in-
creased the input percentage of carbon dioxide to the system dur-
ing the firsthalf ofeachpassage to reduce thepHto7.4. Thecarbon
dioxide input percentage then began to decrease during the sec-
ond half of each passage as the cell numbers expanded, producing
lactic acid and lowering the pH of the culture.
Bioreactor Expansion Does not Change rSKP
Characteristic Protein Expression
Following culture in both static and bioreactor conditions for
three consecutive passages, rSKP marker expression was
assessed by flow cytometry and immunofluorescence (repre-
sentative static immunolabeling shown in the supplemental
online data and supplemental online Fig. 1). rSKPs grown in
the bioreactor culture showed a similar expression profile to
rSKPs grown in static culture (Fig. 3). a-Smooth muscle actin
(a-SMA), which marks DSCs and their progeny residing in the
CTS, was maintained over successive passages and in both cul-
ture systems (Fig. 3C). Other DSC markers, fibroblast-specific
protein 1 (FSP1; Fig. 3D), PDGF receptor-a (PDGFRa; Fig. 3E),
and dermal extracellular matrix protein collagen III (Fig. 3F),
were also maintained in both culture systems. Expression of
the dermal papilla (DP)-specific markers integrin a8 (Fig. 3G)
and versican (Fig. 3J) were both maintained over multiple pas-
sages in both bioreactor and static expansion. SOX2, which is ro-
bustly expressed in the DP and DSCs contained within the
mesenchyme of awl, auchene, and guard hair types, was unde-
tectable after three passages in both conditions (Fig. 3K). A sub-
set of SKPs from both conditions retained nestin expression and
exhibited similar frequencies in both culture systems (Fig. 3H).
Although fibronectin was expressed in a subset of both static
and bioreactor expanded rSKPs, static cultures generated SKPs
with elevated levels of fibronectin (Fig. 3I). Taken together,
we found little phenotypic differences in SKPs exposed to either
static or automated bioreactor expansion conditions (Fig. 3L)
and most DSC markers, with the exception of SOX2, were sus-
tained over multiple passages.
Serial Bioreactor-Expanded rSKPsMaintain Their Ability
to Reconstitute the HF Mesenchyme and Induce
HF Formation
Our previouswork demonstrated that SKPs are able to give rise to
DP and CTS cell types and participate in HF morphogenesis [3].
Therefore, we asked whether bioreactor expansion altered these
functions. Following static or bioreactor culture, rSKPs were in-
jected into the skin and then assessed for their ability to migrate
into and repopulate the HF mesenchyme. Adult rSKPs cultured
grown in either condition were able to home back to existing
HFs and repopulate the mesenchymal compartments (Fig. 4A),
with GFP+ cells taking residence in the dermal cup (the putative
4 Bioreactor-Expanded SKPs Retain Inductive Function
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Figure2. Rat skin-derivedprecursor (rSKP) cells grown in computer-controlled bioreactors produce significantly greater numbers of viable cells
overmultiple passages. (A):Representative images showing rSKPs continue to grow as aggregates over three consecutive passages in static and
bioreactor conditions. (B):Multiplication ratios over serial passages in static and bioreactor conditions. A significant differencewas found in the
multiplication ratios between passages 1 and 2 in bioreactor and static conditions (p, .0001) and between passages 2 and 3 in the bioreactor
condition (p, .05). By the third serial passage, a significant differencewas found in the cumulativemultiplication ratios between the bioreactor
and static conditions (p, .05). (C): Cumulative multiplication ratios over serial passages in static and bioreactor conditions. At the end of each
serial passage, the average aggregate size in the bioreactor condition was significantly smaller than in the static condition (p , .0001). (D):
Average aggregate size of rSKP cells in static and bioreactor conditions. (E): Exponential doubling times in static and bioreactor conditions.
(F, G): The bioreactor condition was under continuous feedback control regulating the dissolved oxygen concentration in the medium at
21% and the pH at 7.4. Scale bars = 200 mm. A two-way analysis of variance (ANOVA) followed by Sidak’s multiple comparison test was used
for (B–D), and a one-way ANOVA followed by Sidak’s multiple comparison test was used for (E). Error bars represent SEM of three independent
experiments. ****, p , .0001; ***, p, .001; *, p , .05.
Agabalyan, Borys, Sparks et al. 5
www.StemCellsTM.com ©AlphaMed Press 2016
ID: srinivasanv Time: 18:51 I Path: //chenas03/Cenpro/ApplicationFiles/Journals/Wiley/SCTM/Vol00602/170009/Comp/APPFile/JW-SCTM170009
438 Bioreactor-Expanded SKPs Retain Inductive Function
Oc 2016 The Authors STEM CELLS TRANSLATIONAL MEDICINE
STEM CELLS TRANSLATIONAL MEDICINE published by Wiley Periodicals, Inc. on behalf of AlphaMed Press
DSC niche), the dermal papilla, and the connective tissue
sheath, suggesting that bipotency is retained. Quantification
of three different transplants per group revealed that the total
number of HFs containing donor GFP+ cells was unaffected by
the growth conditions (13.016 2.733; 8.8586 4.124; Fig. 4B).
Similarly, no significant difference was found in the fate of do-
nor SKPs within the hair follicle niche; that is, the percentage
of those follicles containing GFP+ cells in the DP (86.11 6
13.89; 87.67 6 6.633; Fig. 4C) costained with DP marker ver-
sican did not differ between static versus bioreactor expan-
sion conditions.
We then studiedwhether bioreactor expansion affected their
endogenous inductive. Using the patch assay, we transplanted
donor SKPs grown in either condition, with GFPNEG epithelial ker-
atinocytes. Two weeks later, subcutaneous grafts yielded newly
formed HFs, and most (.95%) of follicles within each graft con-
tained a GFP+ DP, and only these follicles were counted, because
our interestwas in ascertaining the number of follicles induced by
donor SKPs. Newly formed HFs from both conditions contained
mesenchyme thatwas almost entirely composed of GFP+ cells, in-
cluding the DP, dermal cup, and CTS (Fig. 5A, 5B), suggesting that
expansion of inductive adult SKPs in stirred suspension bioreactor
maintains bipotency and at least partially preserves inductive
function. Although bioreactor-grown SKPs retained their capacity
to induce HF morphogenesis, they exhibited a significant reduc-
tion in hair forming ability compared with static-expanded SKPs
(p = .026), with nearly a twofold reduction in GFP+ HFs per graft
(Fig. 5C). Grafts containing bioreactor-expanded SKPs also
showed a greater variation in follicle bulb size and many follicles
exhibiting shorter hair fiber length (Fig. 5B, arrowhead), although
this was not explicitly quantified. In a parallel set of experiments,
we supplemented bioreactor or static SKPswithwild-type neona-
tal dermal cells to enhance donor cell survival and potentially fa-
cilitate integration of bioreactor SKPs. Despite supplementing
with dermal cells, bioreactor-generated SKPs still exhibited im-
paired inductive capacity as shown by a marked reduction in
GFP+ HF formation (p, .02; Fig. 5D). Taken together, stirred sus-
pension bioreactors might serve as a valuable bioprocess plat-
form for controlled (and automated) scale-up of autologous
dermal stem cells or inductive dermal papilla cells with the capac-
ity to partially preserve inductive function even after five pas-
sages in vitro.
DISCUSSION
In the present study, the expansion, morphology, and growth ki-
netics of rSKP cells grown in static culturewas comparedwith rSKP
cells grown in computer-controlled, stirred suspension bioreactor
systems over consecutive passages. Thus, we were working to de-
velop a bioprocess capable of producing clinically relevant numbers
of SKP cells that maintain their functionality in a controlled and re-
producible fashion.
We found that rSKP cells maintain their ex vivo phenotype
over serial passages and continue to grow as suspended, spher-
ical aggregates. In static culture, a subset of aggregates consis-
tently adhered to the surface of the culture flask, and the
frequency of adhesion appeared to increase over passages.
All rSKP aggregates grown in the bioreactor remained in sus-
pension, as the reactors were siliconized before use, thus pre-
venting adhesion to the vessel surface. Based on our previous
work [2], adhesion is indicative of differentiation and would
largely contribute to the limited expansion observed in static
culture. The average size of the rSKP cell aggregates on day 7
was significantly lower in the bioreactor conditions than in
the static cultures. This was likely because of the shear stress
present in the stirred suspension bioreactor, which can have
direct and indirect effects. The optimal hydrodynamic environ-
ment will vary for different cell types and can be determined by
comparing the growth kinetics at different agitation speeds.
The shear stress present in the fluid is dependent on the bio-
reactor and impeller geometry, impeller agitation rate, cell
density, and media viscosity [23]. The maximum shear stress
present at the tip of the impeller in the current bioreactors, op-
erated at 60 rpm was 4.0 dyn/cm2, corresponding to a Kolmo-
gorov eddy size of 150 mm. Particles (i.e., aggregates) larger
than this size would be expected to have interactions and pos-
sible damage from shear. It is predicted that at a lower agita-
tion rate, the average aggregate size in the bioreactor would
increase as cells are less likely to shear apart [24]. Moreover,
we have shown that shear in stirred suspension can play a role
in the stem cell aggregate packing density [25] and expression
of stem cell markers [26]. The aggregate size can also influence
the health of the culture, because nutrients must diffuse
through multiple cell layers to reach cells at the center of the ag-
gregates. However, the small aggregate sizes present in both
the static and the bioreactor systems in this experiment should
not pose any mass transfer resistances to oxygen and nutrient
diffusion [27]. However, cultured SKPs generate colonies that
do not typically exceed 300mm in diameter, suggesting that ag-
gregate size (and hence proliferation) is intrinsically regulated.
Exposure to shear force in stirred suspension bioreactorsmight
liberate single cells from proliferating aggregates, thereby re-
ducing the average colony size and allowing for formation of
new colonies and producing an overall increase in viable cell
number.
Stirred suspension bioreactors, in which culture parame-
ters, including dissolved oxygen, pH, and fluid shear, are
steadily controlled, provide a healthy environment for cells
and often lead to increased cell proliferation. Agitation can
be used to control the size of aggregates and prevent cells from
settling on thebottomof thebioreactor. The agitation rate of 60
rpmwas chosen for the present study based on previous results
that found the agitation rate candirectly influence the diameter
of spherical cell aggregates in 100-ml stirred suspension biore-
actors [25]. Although aggregates in the bioreactor conditions
proved to be smaller than in static culture, the bioreactor
was able to produce a significantly greater number of cells after
three consecutive passages. In general, higher agitation rates
lead to higher shear stresses and smaller aggregates in
stirred suspension bioreactors [10]. An increased expansion
of stem cells in computer-controlled bioreactor systems for
large-scale production has also been documented for mesen-
chymal stem cells [28]. Although the agitation rate in the pre-
sent study was not optimized, it was sufficient to maintain
the aggregates in suspension, maintain high viabilities, and ex-
pand the cells.
Stirred suspension bioreactors, as a scalable method for
cell expansion, although offering a well-mixed delivery of ox-
ygen and nutrients to the cells, also change the geometry and
physical environment of the cells and cell colonies. For exam-
ple, we have shown, for pluripotent stem cells, that gene ex-
pression can be influenced by the shear stress present in the
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Figure3. Characteristic skin-derivedprecursor (SKP)markers inbioreactorversusstatic culture. (A–K):Flowcytometryofsingle-cell ratSKPsgrown
for three consecutivepassagesunder static andbioreactor conditionswasperformed toassess theproteinexpressionofcharacteristic SKPmarkers.
(L): No significant difference was found in the percentage of positive cell expression between the static and bioreactor cultures. Two-tailed t test,
p = nonsignificant. Error bars represent SEM of three independent experiments. Abbreviations: APC-A, allophycocyanin; FB, fibronectin; FSC, for-
ward scatter; FSP1, fibroblast-specific protein 1; PDGFR-a, platelet-derived growth factor receptor-a; PE-A, r-phycoerythrin; a-SMA, a-smooth
muscle actin.
Agabalyan, Borys, Sparks et al. 7
www.StemCellsTM.com ©AlphaMed Press 2016
ID: srinivasanv Time: 18:51 I Path: //chenas03/Cenpro/ApplicationFiles/Journals/Wiley/SCTM/Vol00602/170009/Comp/APPFile/JW-SCTM170009
440 Bioreactor-Expanded SKPs Retain Inductive Function
Oc 2016 The Authors STEM CELLS TRANSLATIONAL MEDICINE
STEM CELLS TRANSLATIONAL MEDICINE published by Wiley Periodicals, Inc. on behalf of AlphaMed Press
bioreactors [26]. Although outside the scope of the present
study, more detailed studies, both computational and exper-
imental, on the effects of this dynamic environment on the
function and population growth kinetics of cells, are neces-
sary before truly robust clinical cell production systems can
be put into widespread use.
The growth kinetic parameters of rSKP cells grown in the
bioreactors did not differ greatly between passages. No signif-
icant difference was found in the exponential doubling times
and no significant difference was seen in the apparent growth
rates between passages. The data from one animal appear in-
consistent with the data from other animals at passage 2, hav-
ing a smaller exponential doubling time and greater apparent
growth rate. By passage 3, however, the kinetic parameters
for all animals were consistent again. Such variations can be at-
tributed to donor variability.
The DASGIP Parallel Bioreactor System (Eppendorf) pro-
vided a controlled system for the expansion of rSKP cells by reg-
ulating the agitation rate, temperature, dissolved oxygen
concentration, and pH. This feedback control is extremely im-
portant in creating a reproducible process, especially when
managing patient-to-patient variability. If cells from a donor ex-
pand at a greater rate, typically more oxygen will be consumed
andmore lactic acidwill be produced, changing the dissolved ox-
ygen concentration and the pH of the culture. In the DASGIP Par-
allel Bioreactor System (Eppendorf), the culture was regulated
at 21% dissolved oxygen and 7.4 pH to mimic the environment
of the human body. Generally, cell culture incubators are set to
input 21% oxygen and 5% carbon dioxide. The DASGIP Parallel
Bioreactor System (Eppendorf) was successful in regulating
the dissolved oxygen concentration and pH of the rSKP culture
during each passage. The DASGIP system does not measure the
nutrient levels within the culture; however, regulated feeding
can be set up to allow glucose and growth factors to be fed
into the reactor at controlled rates. Future work is required
to determine the consumption rates specific to rSKP cells
and the optimal nutrient and growth factor concentrations
within the medium.
To expand SKPs in bioreactors for clinically relevant pur-
poses, it is important for the cells to maintain their phenotype
and HF inductive function. General dermal fibroblast markers
(a-SMA, FSP1, PDGFR a, collagen III) were similarly expressed
after bioreactor or static expansion. Versican, an extracellular
matrix protein found specifically in the inductive mesenchyme
thedermal papilla and connective tissue sheath,was notably ab-
sent (or extremely low) from both populations. Despite this, we
found both rSKP populations maintained their homing and in-
ductive capacity in contrast to previous reports showinga strong
association between versican expression and inductive capacity
[29]. Integrin-a8, which is enriched in the HF mesenchyme and
plays a role in cell-cell adhesion and cell signaling, was sustained
in rSKPs grown in both conditions. An increased expression of
fibronectin was noted in the cells grown under bioreactor con-
ditions, which could be due to stronger cell-cell adhesion prop-
erties under stirred suspension conditions. SOX2 was not
detectable by immunofluorescence after growth of rSKPs in ei-
ther condition. However, this did not appear to influence their
capacity to reconstitute theDP of establishedHFs or their induc-
tive capacity for de novo HF morphogenesis. This is in line with
recent work in which Sox2 was deleted specifically in DP
and failed to elicit an effect on inductive function during HF
morphogenesis [30]. We have previously noted that SKPs isolated
from Sox2:GFP mice also exhibited a loss of GFP expression after
several passages in vitro; however, this was restored after trans-
plantation and reintegration into the HF DP [2]. This suggests that
factorswithin theHFnichemight induce Sox2 expression inDP and
DSCs but is not required for inductive DP function [30]. Additional
work is required to determine whether Sox2 might play a distinct
role in DSCs.
SKPs grownunder both conditionsmaintained their inductive
capabilities and ability to home back to the HF dermal stem cell
niche. However, inductive function was partially diminished after
expansion in stirred suspension bioreactors. Previous work has
demonstrated that the aggregation ofDP cells results in sustained
inductive function relative to monolayer culture [31]. Our data
support that idea but also suggest that other factors could con-
tribute to inductive function. The aggregate size might allow
for important cellular interactions that underlie inductive func-
tion,much like that reported for theDP in vivo [32]. Recent in vivo
work has suggested that aminimum number of cells are required
to sustain normal inductive functions within the adult dermal pa-
pilla. One interpretation of our data is that similar cellular thresh-
olds appear to govern the inductive capacity of SKPs such that
smaller aggregates generated in the bioreactor exhibit differ-
ent functional properties. Biophysical factors such as shear stress
might activate and inadvertently bias the differentiation of SKPs
toward a committed connective tissue sheath fate as opposed to
Figure 4. rSKPs repopulate the hair follicle (HF) mesenchyme after
either bioreactor or static culture. (A): Representative images of en-
dogenous HFs containing transplanted GFP+ rSKPs (green) from static
and bioreactor grown rSKPs. Skin sections were immunostained for
versican (red). (B): Percentage of GFP+ HFs. (C): Percentage of GFP+
dermal papilla HFs between static and bioreactor culture conditions.
Scale bars = 100 mm. Two-tailed t test, p = ns. Error bars represent
SEM of three independent experiments. Abbreviations: DP, dermal
papilla; GFP+, green fluorescent protein positive; ns, not significant;
rSKP, rat skin-derived precursor.
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acquisition of aDPphenotype. Alternatively, changesmight occur
in extracellular matrix production and composition within the
smaller aggregates that are critical mediators of their inductive
function. Future studies will consider the transcriptional status
of cells grown in either condition to better understand the
limited inductive capacity after bioreactor expansion and in
identifying the inductive signals that mediate this process. That
our data show that inductive function is partially retained fol-
lowing extensive cell scale-up is promising. Ongoing experi-
ments will examine additional media supplements that could
be used to sustain inductive function. Moreover, equivalent
shear stress has been shown to modulate Sox2 and other pluri-
potencygenes inembryonic stemcells [26].Therefore,activationof
“stem cell” genes within DSC/SKPs that promote proliferation and
prevent differentiationmight consequently limit the acquisition of
an inductive DP signature [33]. Nevertheless, our data suggest that
the inductive function of adult SKPs is mostly preserved after bio-
reactor expansion. Further optimization of the bioreactor system
(agitation rate, impeller size, volume of culture medium), promo-
tion of aggregate size, and inclusion of additional factors are
needed to sustain the inductive capabilities of SKPs grown in bio-
reactor conditions and increasing the rapid, controlled expansion
of cells.
CONCLUSION
Our results indicate that computer-controlled stirred suspension
bioreactors canbeused for robust expansion of isolated inductive
adult dermal stem cells (SKPs) and, even aftermultiple (n = 5) pas-
sages in vitro, are able to sustain at least apart of their inherentHF
inductive capacity and their ability to repopulate the mesen-
chyme of pre-existing follicles (their endogenous niche). Five
times asmany cellswere obtained in the bioreactor cultures com-
pared with static cultures; thus, using bioreactor expansion early
after isolation might better preserve inductive function, without
limiting the cell yield in a contained and controlled environment.
Overall, this approach might provide a safe and efficient method
to generate large numbers of DSCs, with greater homogeneity,
thereby permitting drug screening for compounds that might in-
fluence HF growth or cell-based strategies to repopulate the skin
and hair follicle after injury or disease.
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Figure 5. GFP rat skin-derived precursors (rSKPs) from bioreactor and
static culture retain their capacity to inducehair follicle (HF)morphogen-
esis. (A): Representative low-magnification images of grafts containing
bioreactor or static culturedGFP+ rSKPs combinedwith keratinocytes af-
ter 14 days. (B): Individually dissected HFs showing integration of GFP+
cells in the dermal papilla (DP) and the connective tissue sheath. (C):
Number of GFP+ HFs formed within grafts containing either static- or
bioreactor-generatedSKPs.Two-tailed t test,p= .023. (D):Quantification
of HF formation in the patch assay, with inclusion of wild-type dermal
fibroblasts to improve survival of donor cells. Note, despite supplement-
ing each graft, bioreactor-expanded GFP+ cells showed a sustained im-
pairment. Error bars represent SEMof three independent experiments.
Imagemagnifications are35 (A) and320 (B). Abbreviation: GFP, green
fluorescent protein.
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